Physician
Valley Tumor Medical Group a Medical Corporation
Valley Tumor Medical Group a Medical Corporation was paid $986K by Medicaid between Jan 2018 and Dec 2024, across 26 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 46% of everything it billed.
33Billing provider infoVALLEY TUMOR MEDICAL GROUP A MEDICAL CORPORATION
PALMDALE, CA 93551
PALMDALE, CA 93551
33aNPI1366584948assigned 02/12/2007
33bProvider typeHematology & Oncology Physician
28Total paid$986K
24GClaims24,866
24DCodes billed26
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in California
Rank by total paid#15 of 180
Median peer was paid$26K
This provider vs. median38×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,473 | $80K | |
| 2019 | 3,051 | $103K | |
| 2020 | 1,924 | $59K | |
| 2021 | 1,632 | $72K | |
| 2022 | 3,463 | $145K | |
| 2023 | 6,721 | $306K | |
| 2024incomplete | 5,602 | $221K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 46% | 11,523 | 9,399 | $457K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 12% | 2,795 | 2,263 | $122K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 6.8% | 1,103 | 647 | $67K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.9% | 789 | 783 | $59K |
| 96367 | 5.7% | 948 | 535 | $56K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.1% | 1,915 | 1,789 | $51K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4.9% | 883 | 494 | $48K |
| 99205 | Prolong outpt/office vis | 3.1% | 500 | 500 | $30K |
| 99223 | Prolong inpt eval add15 m | 2.2% | 306 | 299 | $22K |
| J1756 | Injection, iron sucrose, 1 mg | 2.0% | 581 | 297 | $20K |
| 96368 | 1.1% | 712 | 381 | $11K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1.1% | 898 | 473 | $11K |
14 more codes
| 99232 | Hospital visit by a doctor, follow-up day | 1.0% | 369 | $10K |
| 99497 | <1% | 129 | $5K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 161 | $4K |
| 99490 | Ccm add 20min | <1% | 356 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 177 | $2K |
| 96417 | <1% | 36 | $2K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 128 | $1K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 29 | $955.84 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 177 | $493.14 |
| 96415 | <1% | 18 | $421.23 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 148 | $387.21 |
| 96523 | <1% | 70 | $54.00 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 94 | $43.02 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 21 | $39.24 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHAH, MUKUND (CORPORATE SECRETARY)